Case Report
Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
Table 1
Laboratory data of the patient.
| | WBC | 7530/μL | (3500–9700) | Glucose | 105 mg/dL | (70–109) | | RBC | 427 × 104/μL | (376–516 × 104) | HbA1c (JDS) | 5.5% | (4.3–5.8) | | Plt | 11.5 × 104/μL | (14.0–37.9 × 104) | CRP | 0.25 | (0.00–0.30) | | PT-INR | 1.05 | (0.84–1.14) | CH50 | 44 | (30–45) | | APTT | 46.1 sec | Control: 31.6 sec | C3 | 113 | (80–140) | | TP | 7.7 | (6.7–8.3) | C4 | 25.9 | (11–34) | | Alb | 4.3 | (3.9–4.9) | ANA | 1280 | (<79) | | T-Bil | 0.3 | (0.2–1.2) | DNA/RIA | 11.7 IU/mL | (0.0–6.0) | | AST | 18 IU/L | (8–38) | SS-A | - | | | ALT | 7 IU/L | (4–44) | SS-B | - | | | BUN | 20.2 mg/dL | (8.0–20.0) | aCL-IgG | 35 U/mL | (0–9) | | Cr | 0.85 mg/dL | (0.47–0.79) | Urinalysis | | | | T-CHO | 240 mg/dL | (150–219) | Protein | - | | | HDL-C | 62 mg/dL | (40–90) | OB | - | | | Na | 142 mEq/L | (135–145) | | | | | K | 4.3 mEq/L | (3.5–5.0) | | | | | Cl | 105 mEq/L | (98–108) | | | |
|
|
( ), normal range; ANA, antinuclear antibody; DNA/RIA, anti-DNA antibody/radioimmunoassay; aCL-IgG, anticardiolipin antibody-IgG; OB, occult blood.
|
